Recent News

rss

Important Information

from the State Medical Board of Ohio

Newly Adopted and Amended Rules effective 8/31/17 Bookmark

Newly Adopted and Amended Rules

The Medical Board adopted the following new and amended rules that are effective on 8/31/17:

 

Medical or osteopathic licensure: 4731-6-01, 4731-6-05, 4731-6-10, 4731-6-21, 4731-6-22, 4731-6-30, 4731-6-32, 4731-6-33, 4731-6-34  

Drug treatment of chronic pain: 4731-21-01, 4731-21-02, 4731-21-03 , 4731-21-04, 4731-21-06

Emeritus registration: 4731-22-01, 4731-22-02, 4731-22-07

Mental or physical impairment: 4731-28-01

 

Medical Marijuana Public Rules Hearing: July 10 Bookmark

​A public hearing on proposed rules will be conducted on July 10, 2017 at 1:00 p.m. in the Multipurpose Room, State Fire Marshal’s Office, 8895 E. Main Street, Reynoldsburg, OH 43068. Oral and written testimony may be presented by any person affected by the proposed rules.

Notice of July 10, 2017 Public Hearing

Rules in Chapter 4731-32. The rules concern medical marijuana certificates to recommend, standards of care related to recommending medical marijuana, and petitions to request additional qualifying conditions or diseases.

A Public Rules Hearing Will Be Held on July 26, 2017 Bookmark

A public hearing on proposed rules will be held on July 26, 2017 at 10:00 a.m. in the Lobby Hearing Room, Rhodes State Office Tower, 30 E. Broad Street, 1st Floor, Columbus, OH 43215. Oral and written testimony may be presented by any person affected by the proposed rules.

Notice of July 26, 2017 Public Hearing

Rules 4731-11-01, 4731-11-02 and 4731-11-13

The rules are applicable to the prescribing of controlled substances. Rule 4731-11-13 is proposed as a new rule applicable to prescribing opiate analgesics for acute pain. The rules will be applicable to physicians and physician assistants. 

 

Newly Adopted and Amended Rules Bookmark

The Medical Board adopted new and amended rules that are effective on 6-30-17.

Podiatric licensure rules: 4731-12-01, 4731-12-02, 4731-12-04, 4731-12-05, 4731-12-06 and 4731-12-07. (Please note: Rule 4731-12-03 was filed as a “no change” rule and will continue on without having to be re-adopted.)

Standards and procedures for the operation of a pain management clinic: 4731-29-01

 

A Public Hearing Will Be Held June 23, 2017 Bookmark

​A public hearing will be held on June 23rd at 1:30 p.m. in the Lobby Hearing Room of The Rhodes State Office Tower. It is located at 30 E. Broad Street, 1st Floor, Columbus, Ohio 43215. Oral and written testimony may be presented by any person affected by the proposed rules.

Click here for information about the proposed rule rescissions, amendments and adoptions.

SMBO files Prescribing of Opioid Analgesics for Acute Pain rules with Common Sense Initiative Office. Bookmark

At this time, public comment is being sought on the proposed actions for the following rules. The rule number is a link to the rule and the Business Impact Analysis filed with the Common Sense Initiative.

Prescribing of Opioid Analgesics for Acute Pain

  • 4731-11-01          Definitions (related to controlled substances)

  • 4731-11-02          General provisions (related to controlled substances)

  • 4731-11-13          Prescribing of opioid analgesics for acute pain

  • Business Impact Analysis

  • Comments on the proposed rules must be received no later than May 26, 2017. Please send comments to the Medical Board and to the Common Sense Initiative Office.

  • Please provide comments to both of the following:

  • Questions may be directed to: Sallie Debolt, Senior Counsel, State Medical Board of Ohio at Sallie.Debolt@med.ohio.gov

Proposed Creation of Confidential Monitoring Program Bookmark

The State Medical Board of Ohio (“Medical Board”) invites interested parties to comment on proposed rules that will create a non-disciplinary, confidential monitoring program that allows licensees with mental or physical illnesses, other than substance use disorders, to be monitored by the Medical Board without being subjected to formal public disciplinary action. The program will be entirely within the Medical Board’s investigative process and overseen by the Secretary and Supervising Member of the Medical Board.

If the proposed confidential monitoring program is created, there will be three possible results should the Medical Board receive a complaint alleging that an applicant or licensee is unable to safely practice due to mental or physical illness, excluding substance use disorders. The three possibilities are: (1) the complaint is closed after review, with no public disclosure; (2) the individual is entered into the confidential monitoring program, with no public disclosure; or (3) formal disciplinary action against the individual is proposed, with the action being publicly disclosed. The proposed rules are as follows:

4731-28-02 Eligibility for confidential monitoring program

4731-28-03 Participation in the confidential monitoring program

4731-28-04 Disqualification from continued participation in the confidential monitoring program

4731-28-05 Termination of the participation agreement for the confidential monitoring program

 

Send comments to Sallie.Debolt@med.ohio.gov by Monday, May 1, 2017. 

Board Seeks Comments Regarding Proposed Acute Pain Rules Bookmark

The Medical Board is accepting comments on proposed amendments to two existing rules and a proposed new rule that will limit initial opioid analgesic prescriptions for acute pain to 5 days for minors and 7 days for adults. The rules also include a 30MED average daily dose limit. 

(1) Rule 4731-11-01 Definitions Amended by adding definitions for acute pain, morphine equivalent dose, minor, extended-release or long-acting opioid analgesic, opioid analgesic, palliative care and terminal condition.

(2) Rule 4731-11-02 General Provisions Amended by adding a requirement that physicians and physician assistants must follow Rules 4729-5-30 and 4729-5-13, Ohio Administrative Code. This will include the requirement that prescriptions for controlled substances will need to include the diagnosis.

(3) New Rule 4731-11-13 Prescribing of opioid analgesics for acute pain

  • Limits prescriptions for opioid analgesics to treat acute pain to no more than a seven-day supply for adults and a five-day supply for minors. If the physician determines that the pain is expected to persist for longer than seven days, the physician may prescribe for a longer period, but the reason for exceeding the limits and for prescribing an opioid analgesic must be documented in the patient’s medical record.

  • Requires that the patient and the parent or guardian of a minor patient is advised of the benefits and risks of the opioid analgesic, including the potential for addiction.

  • Clarifies that the rule does not apply to the treatment of patients receiving hospice or palliative care, cancer and terminal illness, or medication assisted treatment for addiction.

​*These proposed rules do not apply to your chronic (long-term) pain patients.

 

Send comments to Sallie.Debolt@med.ohio.gov by Friday, April 28, 2017.

Acute Prescribing Rules Proposed Bookmark

Board President, Dr. Amol Soin, joined Governor John R. Kasich and other leadership to announce new limits on prescription opiates on Thursday, March 30. The state began creating its voluntary guidelines in 2012. After close analysis of the state’s electronic prescribing data in OARRS, Ohio will now take the next step to update its policies to place commonsense limits on opiate prescribing for acute pain. The changes can lead to an estimated reduction of opiate doses in Ohio by 109 million per year while preserving the ability of clinicians to address pain in a competent and compassionate way. These proposed rules will be discussed by the Medical Board during the April 12 policy committee meeting and then proceed into Ohio’s standard rule review and adoption process. Further information and specific prescribing information will be provided by the State Medical Board of Ohio once the rules are finalized, but before they become effective.

 

Acute Prescribing Rules FAQs

For more information on the proposed rules, click here.